Cost–Benefit Evaluation of Interferon and Ribavirin for the Treatment of Hepatitis C in District Dera Ismail Khan, Pakistan. JPEHSS 2026, 4 (1), 129-136. https://doi.org/10.63163/jpehss.v4i1.1040.